论文信息 - Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin - 字舞流文

Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin

Study Objective. To compare the rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin administration.

R. Frothingham | R Frothingham

[1] J. Knoben,et al. An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations. , 1990, American journal of hospital pharmacy.

[2] L. Mandell,et al. Comparative Tolerability of the Newer Fluoroquinolone Antibacterials , 1999, Drug safety.

[3] P. Ball,et al. Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. , 2000, The Journal of antimicrobial chemotherapy.

[4] F. Ponti,et al. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience , 2000, European Journal of Clinical Pharmacology.

[5] R. Owens. Risk Assessment for Antimicrobial Agent‐Induced QTc Interval Prolongation and Torsades de Pointes , 2001, Pharmacotherapy.

[6] P B Iannini,et al. Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. , 2001, The Journal of antimicrobial chemotherapy.

[7] P. Iannini,et al. Evaluating the Risk of Cardiac Toxicity , 2001, Pharmacotherapy.

[8] S. Doddamani,et al. Risk of torsades de pointes with non-cardiac drugs , 2001, BMJ : British Medical Journal.

[9] P. Brown. Avoidance of ingestion of anti-inflammatory drugs in dyspepsia is confounding variable , 2001, BMJ : British Medical Journal.

[10] G. Tillotson,et al. New Milestones Achieved in Fluoroquinolone Safety , 2001, Pharmacotherapy.